Dewey Steadman | executive |
Martine Rothblatt | executive |
Michael Benkowitz | executive |
Terence Flynn | analyst |
Hartaj Singh | analyst |
James Edgemond | executive |
Joseph Thome | analyst |
Eun Yang | analyst |
Leigh Peterson | executive |
Jessica Fye | analyst |
Ashwani Verma | analyst |
Patrick Poisson | executive |
Good morning, and welcome to the United Therapeutics Corporation Third Quarter 2023 Earnings Webcast. My name is Rafael and I will be your conference operator today. [Operator Instructions] Please note, this call is being recorded.
I will now turn the webcast over to Dewey Steadman, Head of Investor Relations, United Therapeutics.